Published on 10/10/2006 in the Prospect News Biotech Daily and Prospect News PIPE Daily.
New Issue: IR Biosciences wraps $2.27 million private placement of units
By Sheri Kasprzak
New York, Oct. 10 - IR Biosciences Holdings, Inc. settled a $2,276,500 private placement.
The company sold 91.06 units at $25,000 each.
Each unit includes 156,250 common shares and a warrant for 78,125 shares.
The warrants are exercisable at $0.50 each for five years.
IR Biosciences, based in Scottsdale, Ariz., is a biotechnology company focused on treatments for radiation exposure.
| Issuer: | IR Biosciences Holdings, Inc.
|
| Issue: | Units of 156,250 shares and warrants for 78,125 shares
|
| Amount: | $2,276,500
|
| Units: | 91.06
|
| Price: | $25,000
|
| Warrants: | For 78,125 shares per unit
|
| Warrant expiration: | Five years
|
| Warrant strike price: | $0.50
|
| Settlement date: | Oct. 4
|
| Stock symbol: | OTCBB: IRBO
|
| Stock price: | $0.20 at close Oct. 4
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
